Classification: Snake (animal group), Viperidae (family), Vipera (genus) Geographic area: Europe, Western Europe, North Africa, Russia, Middle East, North Asia, West Asia Indicated antivenom:Nr | Antivenom | Number of holding centres | 1. | Anti Vipera palestinae [Felsenstein Medical Research Center, Israel] | 0 | 2. | Anti-viper venom [Federal State Company for Immunobiological Medicines (Microgen), Russian Federation] | 0 | 3. | EUROPEAN VIPER VENOM ANTISERUM [Inst. of Immunology, Croatia] | 38 (vials total 168) | 4. | Monovalent [National Center of Infectious and Parasitic Diseases, Bulgaria] | 0 | 5. | Polyvalent Anti-vipers Venom [VACSERA, Egypt] | 0 | 6. | Polyvalent Snake Antivenin [Razi Serum and Vaccine Research Institute, Iran] | 0 | 7. | Polyvalent Snake Venom Antiserum [VACSERA, Egypt] | 0 | 8. | Viper Venom Antitoxin [Torlak, Institute of Virology, Vaccines and Sera, Serbia] | 0 | 9. | Viper venom antitoxin (BIOMED) [BIOMED (Wytwornia Surowic i Szczepionek), Poland] | 0 | 10. | ViperaTAb (UK) [MicroPharm Ltd, United Kingdom] | 4 (vials total 30) | 11. | Viperfav [Sanofi-Pasteur MSD, France] | 7 (vials total 19) |
|